Article
Human serum and platelet lysate are appropriate xeno-free alternatives for clinical-grade production of human MuStem cell batches
2 May 2018
Abstract excerpt
BACKGROUND: Canine MuStem cells have demonstrated regenerative efficacy in a dog model of muscular dystrophy, and the recent characterization of human counterparts (hMuStem) has highlighted the therapeutic potential of this muscle-derived stem cell population. To date, these cells have only been generated in research-grade conditions. However, evaluation of the clinical efficacy of any such therapy will require...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
